The Adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population

Gene

Volumn 534, Issue 1, 2014, Pages 10-16

  Arikoglu, Hilal ^a   Ozdemir, Hulya ^a   Kaya, Dudu Erkoc ^a   Ipekci, Suleyman Hilmi ^a   Arslan, Ahmet ^b   Kayis, Seyit Ali ^a   Gonen, Mustafa Sait ^c  

^a SELCUK UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Adiponectin gene; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC PATIENT; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; SILENCER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; EXONS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 84888037570     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.10.039     Document Type: Article

References (75)

1. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000, 11:327-332.
2. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
3. Biswas D., Vettriselvi v., Choudhury J., Jothimalar R., et al. Adiponectin gene polymorphism and its association with type 2 diabetes mellitus. Indian J. Clin. Biochem. 2011, 26:172-177.
4. Busfield F., Duffy D.L., Kesting J.B., et al. A genome wide search for type 2 diabetes-susceptibility genes in indigenous Australians. Am. J. Hum. Genet. 2002, 70:349-357.
5. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 2002, 3:285-298.
6. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R., et al. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
7. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L., et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 2001, 108:1875-1881.
8. Dabney A., Storey J.D., Warnes G.R. qvalue: Q-value estimation for false discovery rate control. R package version 1.30.0 2004.
9. Dastani Z., Hivert M.F., Timpson, et al. Novel loci for Adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012, 8.
10. Duncan M.H., Singh B.M., Wise P.H., Carter G., Alaghband-Zadeh J., et al. A single measure of insulin resistance. Lancet 1995, 346:120-121.
11. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R., et al. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001, 507:142-146.
12. Filippi E., Sentinelli F., Trischitta V., et al. Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet. 2004, 12:199-205.
13. Francke S., Manraj M., Lacquemant C., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 2001, 10:2751-2765.
14. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316:129-139.
15. Gibson F., Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004, 53:2977-2983.
16. Gong M., Long J., Liu Q., Deng H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol. Cell. Endocrinol. 2010, 325:78-83.
17. Gonzales-Sanchez J.L., Zabena C.A., Martinez-Larrad M.T., et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes. Res. 2005, 13:807-812.
18. Han L.Y., Wu Q.H., Jiao M.L., et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011, 54:2303-2314.
19. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
20. Heid L.M., Henneman P., Hicks A., et al. Clear detection of ADİPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
21. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
22. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
23. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 1996, 271:10697-10703.
24. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
25. Kim S., Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte. J. Nutr. 2000, 130:3110-3115.
26. Kim J.H., Shin H.F., Park B.L., et al. Peroxisome proliferators-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population. Diabetologia 2005, 48:1323-1330.
27. Kita A., Yamasaki H., Kuwahara H., et al. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 2005, 331:484-490.
28. Kondo H., Shimomura I., Matsukawa Y., et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002, 51:2325-2328.
29. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 2003, 23:85-89.
30. Laumen H., Saningong A.D., Heid I.M., et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009, 58:984-991.
31. Li S., Shin H.J., Ding E.L., van Dam R.M., et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302:179-188.
32. Li Y.Y., Yang Z.J., Zhou C.W., et al. Adiponectin -11377CG gene polymorphism and type 2 diabetes mellitus in the Chinese population: a meta analysis of 6425 subjects. PLoS One 2013, 8.
33. Matsubara M., Maruoka S., Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 2002, 87:2764-2769.
34. Menzaghi C., Ercolino T., Di Paola R., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51:2306-2312.
35. Miyazaki T., Bub J.D., Uzuki M., Iwamoto Y., et al. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem. Biophys. Res. Commun. 2005, 333:79-87.
36. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K., et al. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
37. Park S.K., Oh S.Y., Lee M.Y., Yoon S., Kim K.S., Kim J.W., et al. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 2004, 53:2757-2766.
38. Pollin T.I., Tanner K., O'Connell J.R., et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 2005, 54:268-274.
39. Poulsen P., Anderson G., Fenger M., et al. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?. Diabetes 2003, 52(1):194-198.
40. Qiao L., Maclean P.S., Schaack J., et al. C/EBP alpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005, 54:1744-1754.
41. R Development Core Team R A Language and Environment for Statistical Computing 2010, R Foundation for Statistical Computing, Vienna, Austria, (http://www.R-project.org 15 December).
42. Rasche A., Al-Hasani H., Herwig R. Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus. BMC Genomics 2008, 9:310-327.
43. Richards A.A., Stephens T., Charlton H.K., et al. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol. Endocrinol. 2006, 20:1673-1687.
44. Richards J.B., Waterworth D., O'Rahilly S., et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009, 5.
45. Saito K., Tobe T., Minoshima S., et al. Organization of the gene for gelatin-binding protein (GBP28). Gene 1999, 229:67-73.
46. Schaffler A., Langmann T., Palitzsch K.D, Schölmerich J., Schmitz G., et al. Identification and characterization of the human adipocyte apM-1 promoter. Biochim. Biophys. Acta 1998, 1399:187-197.
47. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
48. Schwarz P.E., Towers G.W., Fischer S., et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADİPOQ gene promoter. Diabetes Care 2006, 29:1645-1650.
49. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
50. Shapiro L., Scherer P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 1998, 8:335-338.
51. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
52. Staiger H., Machicao F., Fritsche A., Haring H.U. Pathomechanisms of type 2 diabetes genes. Endocr. Rev. 2009, 30:557-585.
53. Storey J.D., Taylor J.E., Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: a unified approach. J. R. Stat. Soc. Ser. B 2004, 66:187-205.
54. Sun H., Gong Z.C., Yin J.Y., et al. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br. J. Clin. Pharmacol. 2008, 65:917-926.
55. Supriyaprom K., Phonrat B., Namjuntra P., Harnroongroj T., Tungtrongchitr R., et al. The -11377C>G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais. Int. J. Vitam. Nutr. Res. 2010, 80:216-224.
56. Takahashi M., Arita Y., Yamagata K., et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord. 2000, 24:861-868.
57. Tomas E., Tsao T.S., Saha A.K., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16309-16313.
58. Tonjes A., Scholz M., Loeffler M., Stumwoll M. Association of Pro12Ala polymorphism in peroxisome proliferators-activated receptor gamma with pre-diabetic phenotypes: meta-analyses of 57 studies on nondiabetic individuals. Diabetes Care 2006, 29(11):2489-2497.
59. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S., et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
60. Vasseur F. The genetics of adiponectin. Int. Congr. Ser. 2003, 1253:37-44.
61. Vasseur F., Helbecque N., Dina C., et al. Single-nucleotide polymorphism haplotypes in the both proxiimal promer and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contrbute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet. 2002, 11:2607-2614.
62. Vasseur F., Helbecque N., Lobbens S., et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005, 48:892-899.
63. Vionnet N., Hani E.H., Dupont S., et al. Genomewide search for type 2 diabetesc susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 2000, 67:1470-1480.
64. Waki H., Yamauchi T., Kamon J., et al. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J. Biol. Chem. 2003, 278:40352-40363.
65. Wang Y., Xu A., Knight C., Xu L.Y., Cooper G.J.S., et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin: potential role in the modulation of its insulin-sensitizing activity. J. Biol. Chem. 2002, 277:19521-19529.
66. Wang Y., Lam K.S., Yau M.H., Xu A., et al. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 2008, 409:623-633.
67. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
68. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B., et al. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes. Metab. 2006, 8:264-280.
69. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
70. Yang W.S., Jeng C.Y., Wu T.J., et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002, 25:376-380.
71. Yang W.S., Lee W.J., Funahashi T., et al. Plasma adiponectin levels in overweight and obese Asians. Obes. Res. 2002, 10:1104-1110.
72. Yang W.S., Yang Y.C., Chen C.L., et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am. J. Clin. Nutr. 2007, 86:509-513.
73. Yang M., Qiu C.C., Chen W., Xu L.L., Yu M., Xiang H.D., et al. Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality. Biomed. Environ. Sci. 2008, 21:454-459.
74. Zacharova J., Chiasson J.L., Laakso M. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 2005, 54:893-899.
75. Zeggini E., Scott L.J., Saxena R., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40:638-645.